Select Medical Holdings Corporation (SEM)
NYSE: SEM · Real-Time Price · USD
14.92
+0.23 (1.57%)
At close: May 9, 2025, 4:00 PM
15.33
+0.41 (2.75%)
Pre-market: May 12, 2025, 7:04 AM EDT
Select Medical Holdings Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Select Medical Holdings stock ranges from a low of $19 to a high of $42. The average price target of $27.33 forecasts a 83.18% increase in the stock price over the next year.
Price Target: $27.33 (+83.18%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Select Medical Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Buy Maintains $23 → $19 | Buy | Maintains | $23 → $19 | +27.35% | May 7, 2025 |
RBC Capital | RBC Capital | Buy Maintains $47 → $23 | Buy | Maintains | $47 → $23 | +54.16% | Feb 24, 2025 |
UBS | UBS | Hold Maintains $40 → $21 | Hold | Maintains | $40 → $21 | +40.75% | Jan 3, 2025 |
Benchmark | Benchmark | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 25, 2024 |
RBC Capital | RBC Capital | Buy Maintains $40 → $47 | Buy | Maintains | $40 → $47 | +215.01% | Nov 4, 2024 |
Financial Forecast
Revenue This Year
5.53B
from 5.19B
Increased by 6.55%
Revenue Next Year
5.85B
from 5.53B
Increased by 5.84%
EPS This Year
1.12
from 1.70
Decreased by -34.13%
EPS Next Year
1.39
from 1.12
Increased by 23.83%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 5.8B | 6.2B | 6.6B |
Avg | 5.5B | 5.9B | 6.1B |
Low | 5.3B | 5.5B | 5.8B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 11.4% | 11.9% | 12.5% |
Avg | 6.6% | 5.8% | 4.9% |
Low | 1.9% | 0.3% | -1.3% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 1.22 | 1.62 | 1.97 |
Avg | 1.12 | 1.39 | 1.62 |
Low | 1.01 | 1.21 | 1.41 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | -28.3% | 44.5% | 42.5% |
Avg | -34.1% | 23.8% | 16.9% |
Low | -40.6% | 7.7% | 1.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.